IHS Chemical Week

Regions :: Western Europe :: France

Sanofi-Aventis to Acquire U.S. Biopharma Firm

June 30, 2010 | Deepti Ramesh

Sanofi-Aventis (Paris) says it has signed an agreement to acquire TargeGen (San Diego, CA), a privately held biopharmaceutical company developing small molecule kinase inhibitors for the treatment of certain forms of leukemia, lymphoma and other hematological malignancies and blood disorders. Sanofi-Aventis will make an upfront payment of $75 million upon closing of the transaction, and further milestones payments at different stages of development of TargeGen lead product TG 101348. The total payments, including the upfront payment, could reach $560 million. The...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.


contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa